Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study

Study Title
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
Teva Identifier
TVP - 1012/133a
ClinicalTrials.gov Identifier
NCT00203125
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: rasagiline mesylate | Other: tyramine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
Child, Adult, Older Adult
Trial Duration
10/01/2000 - 01/01/2003
Phase
Phase 3

Study Type

Interventional